Skip to main content

HbA1c Measures Higher in South Asians Than White Europeans


July 27, 2012 — Three measures of blood sugar — glycated hemoglobin (HbA1c) levels, fasting plasma glucose (FPG), and 2-hour β-plasma glucose (2hrPG) — were higher on average in South Asians than white Europeans regardless of other factors associated with glycemic control, according to results from a new study published online June 14 and in the August print issue of Diabetes Care.
Samiul A. Mostafa, MBCHB, from the Department of Cardiovascular Sciences, University of Leicester, United Kingdom, and colleagues analyzed screening data from 6040 people aged 40 to 75 years between 2005 and 2009. The data included 1352 South Asians and 4688 white Europeans.
The analysis showed HbA1c glucose levels to be significantly associated with ethnicity, FPG, 2hrPG, and homeostasis model assessment of β-cell function (P = .001), age and sex (P = .01), and fasting insulin and potassium (P = .05). When these and other risk factors were adjusted for, South Asians had higher levels, compared with white Europeans, of HbA1c (6.22% and 6.02%, respectively; mean difference, 0.19%; 95% confidence interval [CI], 0.11 - 0.27; P < .001), FPG (5.15 and 5.30 mmol/L, respectively; mean difference, 0.15 mmol/L; 95% CI, 0.09 - 0.21; P < .001), and 2hrPG (5.82 and 6.57 mmol/L, respectively; mean difference, 0.75 mmol/L; 95% CI, 0.59 - 0.92; P < .001).
Earlier studies have shown higher HbA1c levels to be independent of factors associated with glycemic control among blacks (by from 0.2% to 0.4%), Hispanics (by from 0.1% to 0.3%), and Southeast Asians (by from 0.2% to 0.3%). The authors say this study is the first to demonstrate the effect in South Asians.
The authors note that international organizations recommend the use of ethnic-specific targets for South Asians for body mass index, waist size, and metabolic syndrome, but not for HbA1c levels. A smaller percentage of South Asians with diabetes hit glycemic targets compared with white Europeans.
"Because our study demonstrates independently higher HbA1c, FPG, and 2hrPG levels in South Asians, this result may be partially explained by factors related to glycemia," the authors conclude. "Future research should address the relationship between HbA1c and the onset of diabetes complications, including prevalent retinopathy, between South Asians and white Europeans in well-designed outcome studies to determine if ethnic-specific cut points are required for diabetes diagnosis in South Asians."
The study was funded by the United Kingdom (UK) National Health Service Department of Health. Dr. Mostafa and a coauthor have received fellowships from Novo Nordisk UK Research Foundation; 2 coauthors have received research funds and honoraria for speaking at meetings and serving on advisory boards for Astra Zeneca, Eli Lilly, sanofi aventis, Merck Sharp & Dohme, Novo Nordisk, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Pfizer, and/or Servier. Two of the researchers serve as members of the National Institute for Health and Clinical Excellence Public Health Guidance on Prevention of Type 2 Diabetes Among People With Prediabetes and are advisors to the UK Department of Health for the NHS Health Checks Programme. .The other authors have disclosed no relevant financial relationships.

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

FDA Decision Delayed for Truvada in HIV PrEP

June 11, 2012 — The US Food and Drug Administration (FDA) has delayed its decision on allowing the use of tenofovir disoproxil fumarate/emtricitabine ( Truvada , Gilead) as preexposure prophylaxis (PrEP) so that the proposed risk evaluation and mitigation strategy (REMS) can be reviewed. In early May, the FDA's Antiviral Drugs Advisory Committee  strongly backed  approval of the first-ever drug for the prevention of sexually acquired HIV-1 infection. However, concerns by the panel at the time included that people may neglect condom use if they feel they are protected by PrEP. Panelists were also concerned that uninfected people taking PrEP who become infected with HIV may not switch to a 3-drug regimen as recommended. According to the company, the FDA has postponed the target date to September 14 so it can review Gilead's REMS plan to help ensure that patients will not misuse the drug. The committee's recommendation for supplemental approval of tenofovir/emtricit...
Post a Comment
Read more

Antidepressants Linked to Higher Diabetes Risk in Kids

Pediatric patients who use antidepressants may have an elevated risk for type 2 diabetes, the authors of a new study report. In a retrospective cohort study of more than 119,000 youths 5 to 20 years of age, the risk for incident type 2 diabetes was nearly twice as high among current users of certain types of antidepressants as among former users, Mehmet Burcu, PhD, and colleagues report in an article  published online October 16 in  JAMA Pediatrics . The risk intensified with increasing duration of use, greater cumulative doses, and higher daily doses of these antidepressants. The findings point to a growing need for closer monitoring of these products, including greater balancing of risks and benefits, in the pediatric population, the authors caution. They undertook the study because, despite growing evidence of an association between antidepressant use and an increased risk for type 2 diabetes in adults, similar research in pediatric patients was scarce. "To our know...
Post a Comment
Read more